John C. Horlander

609 total citations
8 papers, 307 citations indexed

About

John C. Horlander is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, John C. Horlander has authored 8 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 1 paper in Surgery. Recurrent topics in John C. Horlander's work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Hepatitis C virus research (3 papers). John C. Horlander is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Hepatitis C virus research (3 papers). John C. Horlander collaborates with scholars based in United States, Spain and Portugal. John C. Horlander's co-authors include Naga Chalasani, Paul Y. Kwo, Lawrence Lumeng, Helena Hoen, Stephan M. Stockberger, Areen Said, Juan Maya, Scott Herring, Ali Asghar and Michael Schenk and has published in prestigious journals such as Journal of the American Society of Nephrology, The American Journal of Gastroenterology and British Journal of Clinical Pharmacology.

In The Last Decade

John C. Horlander

8 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Horlander United States 6 192 181 46 36 35 8 307
K. Shiva Kumar United States 10 177 0.9× 328 1.8× 24 0.5× 52 1.4× 89 2.5× 23 460
M Armigliato Italy 11 172 0.9× 202 1.1× 53 1.2× 17 0.5× 92 2.6× 26 419
Géraldine Lamblin France 10 222 1.2× 179 1.0× 34 0.7× 25 0.7× 90 2.6× 15 387
Shou‐Dong Lee Taiwan 13 369 1.9× 317 1.8× 28 0.6× 38 1.1× 129 3.7× 21 467
Cheng-Shyong Wu Taiwan 8 111 0.6× 118 0.7× 55 1.2× 35 1.0× 123 3.5× 10 319
Waseem Amjad United States 12 112 0.6× 122 0.7× 29 0.6× 22 0.6× 86 2.5× 45 316
Naoki Kawagishi Japan 12 248 1.3× 213 1.2× 66 1.4× 32 0.9× 90 2.6× 41 434
И. Г. Бакулин Russia 10 136 0.7× 223 1.2× 45 1.0× 31 0.9× 95 2.7× 124 472
Moon Kwan Chung South Korea 6 229 1.2× 181 1.0× 29 0.6× 35 1.0× 155 4.4× 18 343

Countries citing papers authored by John C. Horlander

Since Specialization
Citations

This map shows the geographic impact of John C. Horlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Horlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Horlander more than expected).

Fields of papers citing papers by John C. Horlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Horlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Horlander. The network helps show where John C. Horlander may publish in the future.

Co-authorship network of co-authors of John C. Horlander

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Horlander. A scholar is included among the top collaborators of John C. Horlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Horlander. John C. Horlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Leighton, Jonathan A., Debra J. Helper, Pramod Malik, et al.. (2014). The Novel PillCam Crohn’s Disease Capsule Demonstrates Similar Diagnostic Yield as Ileocolonoscopy in Patients With Active Crohn’s Disease: A Prospective Multicenter International Cohort Study. The American Journal of Gastroenterology. 109. S497–S498. 1 indexed citations
2.
Horlander, John C., Naga Chalasani, Mitchell A. Hamman, et al.. (2005). Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein. British Journal of Clinical Pharmacology. 59(4). 440–446. 26 indexed citations
3.
Liangpunsakul, Suthat, et al.. (2003). Positron emission tomography for detecting occult hepatocellular carcinoma in hepatitis C cirrhotics awaiting for liver transplantation. Transplantation Proceedings. 35(8). 2995–2997. 8 indexed citations
4.
Chalasani, Naga, et al.. (2001). Effects of Albumin/Furosemide Mixtures on Responses to Furosemide in Hypoalbuminemic Patients. Journal of the American Society of Nephrology. 12(5). 1010–1016. 73 indexed citations
5.
Brater, D. Craig, Naga Chalasani, J. Christopher Gorski, et al.. (2001). Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.. PubMed. 112. 108–15; discussion 116. 2 indexed citations
6.
Chalasani, Naga, John C. Horlander, Areen Said, et al.. (1999). Screening for Hepatocellular Carcinoma in Patients With Advanced Cirrhosis. The American Journal of Gastroenterology. 94(10). 2988–2993. 111 indexed citations
7.
Horlander, John C., Michael Schenk, Stanley A. Herring, et al.. (1999). Vaccination against Hepatitis B in Patients with Chronic Liver Disease Awaiting Liver Transplantation. The American Journal of the Medical Sciences. 318(5). 304–304. 28 indexed citations
8.
Horlander, John C., et al.. (1999). Vaccination against Hepatitis B in Patients with Chronic Liver Disease Awaiting Liver Transplantation. The American Journal of the Medical Sciences. 318(5). 304–307. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026